Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 2
1985 1
1986 1
1987 2
1988 3
1989 2
1990 2
1991 1
1993 3
1994 6
1995 6
1996 10
1997 13
1998 16
1999 27
2000 31
2001 41
2002 43
2003 41
2004 79
2005 100
2006 133
2007 113
2008 140
2009 149
2010 162
2011 148
2012 190
2013 160
2014 171
2015 171
2016 158
2017 141
2018 147
2019 101
2020 112
2021 129
2022 112
2023 91
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

2,610 results

Results by year

Filters applied: . Clear all
Page 1
Melatonin Receptor Gene Polymorphism in Bipolar-I Disorder.
Mulayim E, Karababa İF, Akbaş H, Bayazıt H, Selek S. Mulayim E, et al. Arch Med Res. 2021 Jul;52(5):523-528. doi: 10.1016/j.arcmed.2021.01.002. Epub 2021 Feb 2. Arch Med Res. 2021. PMID: 33546869
BACKGROUND AND AIM: In patients with Bipolar-I Disorder (BD-I), circadian rhythm and sleep disorders are frequently observed. ...
BACKGROUND AND AIM: In patients with Bipolar-I Disorder (BD-I), circadian rhythm and sleep disorders are frequently obs …
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
Monahan C, McCoy L, Powell J, Gums JG. Monahan C, et al. Ann Pharmacother. 2022 Sep;56(9):1049-1057. doi: 10.1177/10600280211070330. Epub 2022 Jan 18. Ann Pharmacother. 2022. PMID: 35040357 Review.
DATA SYNTHESIS: In June 2021, the Food and Drug Administration (FDA) approved Lybalvi() (olanzapine/samidorphan) for indications including treatment of adults with schizophrenia and/or bipolar I disorder (acute manic episodes or acute episodes with mixed feat …
DATA SYNTHESIS: In June 2021, the Food and Drug Administration (FDA) approved Lybalvi() (olanzapine/samidorphan) for indications including t …
Bipolar I Disorder Exacerbation Following COVID-19 Vaccination.
Guina J, Barlow S, Gutierrez D. Guina J, et al. Innov Clin Neurosci. 2022 Jul-Sep;19(7-9):9-11. Innov Clin Neurosci. 2022. PMID: 36204171 Free PMC article.
We present the cases of a 60-year-old female patient and 40-year-old male patient who experienced exacerbations of previously well-controlled symptoms of bipolar I disorder (BD1) after receiving COVID-19 vaccines, despite being stable for years on the same me …
We present the cases of a 60-year-old female patient and 40-year-old male patient who experienced exacerbations of previously well-controlle …
Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.
Pham H, Warlick H, Bermudez R, Nguyen Q, Rey JA. Pham H, et al. J Pharm Technol. 2022 Oct;38(5):304-313. doi: 10.1177/87551225221114281. Epub 2022 Jul 29. J Pharm Technol. 2022. PMID: 36046346 Free PMC article. Review.
OBJECTIVE: To review the pharmacology, pharmacokinetics, and efficacy and safety data of a combination of olanzapine and samidorphan (OLZ/SAM) for the treatment of schizophrenia and bipolar I disorder, which mitigates the possible unwanted side effects of wei …
OBJECTIVE: To review the pharmacology, pharmacokinetics, and efficacy and safety data of a combination of olanzapine and samidorphan (OLZ/SA …
Cariprazine (Vraylar): CADTH Reimbursement Recommendation: Indication: As monotherapy for: bipolar mania: acute management of manic or mixed episodes associated with bipolar I disorder in adults, and bipolar depression: acute management of depressive episodes associated with bipolar I disorder in adults.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov. PMID: 38620361 Free Books & Documents. Review.
ADDITIONAL INFORMATION: WHAT IS BIPOLAR I DISORDER? Bipolar I disorder is a condition defined by episodes of mania and depression. ...It is estimated that 0.87% of those living in Canada are living with bipolar I disorder …
ADDITIONAL INFORMATION: WHAT IS BIPOLAR I DISORDER? Bipolar I disorder is a condition defined by e …
Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
Stepanova E, Grant B, Findling RL. Stepanova E, et al. Paediatr Drugs. 2018 Apr;20(2):121-134. doi: 10.1007/s40272-017-0274-9. Paediatr Drugs. 2018. PMID: 29170943 Free PMC article. Review.
In clinical trials, asenapine was generally safe and well tolerated in pediatric patients with bipolar I disorder and schizophrenia. Serious adverse effects were generally related to worsening of the underlying psychiatric disorder. ...Extrapyramidal symptom …
In clinical trials, asenapine was generally safe and well tolerated in pediatric patients with bipolar I disorder and s …
Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults.
Aggarwal A, Schrimpf L, Lauriello J. Aggarwal A, et al. Clin Schizophr Relat Psychoses. 2018 Jan;11(4):221-223. doi: 10.3371/CSRP.AGSC.010318. Clin Schizophr Relat Psychoses. 2018. PMID: 29341822 Review.
Bipolar I disorder is a serious and disabling psychiatric illness. ...
Bipolar I disorder is a serious and disabling psychiatric illness. ...
Cognitive profiles in bipolar I disorder and associated risk factors: Using Wechsler adult intelligence scale-IV.
Ko H, Park D, Shin J, Yu R, Ryu V, Lee W. Ko H, et al. Front Psychol. 2022 Oct 6;13:951043. doi: 10.3389/fpsyg.2022.951043. eCollection 2022. Front Psychol. 2022. PMID: 36275296 Free PMC article.
Accordingly, the present study aimed to examine the cognitive profile of bipolar I disorder (BD-I) patients and associated risk factors. METHODS: Participants included 45 patients, diagnosed with BD-I, current or most recent episode manic, and matching 46 hea …
Accordingly, the present study aimed to examine the cognitive profile of bipolar I disorder (BD-I) patients and associa …
2,610 results